410 filings
Page 13 of 21
4
kjiyku0
31 Aug 21
Cerevel Therapeutics / JOSEPH EDELMAN ownership change
2:15pm
25-NSE
cxpoc3hi0f1xw
30 Aug 21
Exchange delisting
4:24pm
4
blwqgbk
25 Aug 21
Cerevel Therapeutics / JOSEPH EDELMAN ownership change
7:14pm
424B3
snx9wnc
11 Aug 21
Prospectus supplement
4:30pm
8-K
q85avsv m8k
11 Aug 21
Cerevel Therapeutics Reports Second Quarter 2021 Financial Results and Business Updates
7:33am
SC 13G
tjca7rlz5c
10 Aug 21
Cerevel Therapeutics / FMR ownership change
10:33am
424B3
onm2d9l
30 Jul 21
Prospectus supplement
7:15am
8-K
s9lwzh0
30 Jul 21
Cerevel Therapeutics Announces Redemption of Public Warrants
7:12am
4
veft6oz16as g6f2wgbu
9 Jul 21
Cerevel Therapeutics / JOSEPH EDELMAN ownership change
6:39pm
SC 13D/A
450nq5dlq1gstlio6oq
9 Jul 21
Cerevel Therapeutics / BC Perception ownership change
5:05pm
SC 13D/A
slef3kg0
9 Jul 21
Cerevel Therapeutics / PFIZER ownership change
4:16pm
424B4
q9dh9
2 Jul 21
Prospectus supplement with pricing info
5:22pm
424B3
hfp68mzyb pbvb5
2 Jul 21
Prospectus supplement
6:13am
8-K
x2skh00q4v5vkpw2h
2 Jul 21
Cerevel Therapeutics Announces Pricing of $350 Million Public Offering of Common Stock
6:07am
EFFECT
yu1o3
2 Jul 21
Notice of effectiveness
12:15am
424B3
9wqi kfc7
29 Jun 21
Prospectus supplement
6:57am
8-K
so3 qjjka60qpyei
29 Jun 21
Cerevel Therapeutics Announces Positive Topline Results for CVL-231 in Phase 1b
6:52am
CORRESP
exlmbew33kom
29 Jun 21
Correspondence with SEC
12:00am